Susquehanna International Group’s Annovis Bio ANVS Stock Holding History

Susquehanna International Group’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$498K	Buy	223,300 +14,200	+7%	+$38.9K	﹤0.01%	9677
2025 Q4	$723K	Buy	209,100 +163,400	+358%	+$491K	﹤0.01%	7952
2025 Q3	$94.6K	Sell	45,700 -11,400	-20%	-$28.5K	﹤0.01%	11600
2025 Q2	$124K	Buy	57,100 +29,600	+108%	+$58.4K	﹤0.01%	11653
2025 Q1	$41.3K	Sell	27,500 -293,200	-91%	-$897K	﹤0.01%	11920
2024 Q4	$1.61M	Buy	320,700 +135,700	+73%	+$982K	﹤0.01%	5783
2024 Q3	$1.49M	Sell	185,000 -149,900	-45%	-$1.4M	﹤0.01%	5923
2024 Q2	$1.93M	Buy	334,900 +114,400	+52%	+$927K	﹤0.01%	5171
2024 Q1	$2.62M	Buy	220,500 +136,900	+164%	+$1.49M	﹤0.01%	4771
2023 Q4	$1.56M	Buy	+83,600	New	+$741K	﹤0.01%	5900

Other funds holding ANVS

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Susquehanna International Group's ANVS Position: Q1 2026 in Review

Susquehanna International Group reduced its Annovis Bio (ANVS) stake by 28% in Q1 2026, selling an estimated $233K and leaving 218,336 shares worth $487K. The position accounts for ﹤0.01% of the portfolio, ranked #9740.

Susquehanna International Group first reported a position in ANVS in Q1 2023 and has held it in 10 quarters since. The position peaked at $1.05M in Q4 2025. 56 funds tracked by Wall St. Rank hold ANVS as of Q1 2026.

Susquehanna International Group held 218,336 shares of Annovis Bio worth $487K as of Q1 2026.
Susquehanna International Group sold 84,951 Annovis Bio shares in Q1 2026, an estimated $233K.
Annovis Bio made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9740 holding.
Susquehanna International Group first reported a position in Annovis Bio in Q1 2023 and has held it in 10 quarters since.
Susquehanna International Group's Annovis Bio position peaked at $1.05M in Q4 2025.
56 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.